Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
In the latest session, Supernus Pharmaceuticals Inc (NASDAQ: SUPN) closed at $30.00 down -4.15% from its previous closing price of $31.30. In other words, the price has decreased by -$4.15 from its previous closing price. On the day, 1.07 million shares were traded. SUPN stock price reached its highest trading level at $32.87 during the session, while it also had its lowest trading level at $29.04.
Ratios:
For a deeper understanding of Supernus Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.54 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 16.52. For the most recent quarter (mrq), Quick Ratio is recorded 1.49 and its Current Ratio is at 1.73. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Jefferies Upgraded its Hold to Buy on April 13, 2021, whereas the target price for the stock was revised from $25 to $40.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 21 ’24 when Bhatt Padmanabh P. sold 14,491 shares for $35.31 per share. The transaction valued at 511,677 led to the insider holds 8,570 shares of the business.
Bhatt Padmanabh P. sold 400 shares of SUPN for $14,124 on Mar 20 ’24. The Sr. VP of IP, CSO now owns 8,570 shares after completing the transaction at $35.31 per share. On Mar 19 ’24, another insider, Bhatt Padmanabh P., who serves as the Sr. VP of IP, CSO of the company, sold 12,364 shares for $35.31 each. As a result, the insider received 436,573 and left with 8,570 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SUPN now has a Market Capitalization of 1721252992 and an Enterprise Value of 1384217472. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.76 while its Price-to-Book (P/B) ratio in mrq is 1.77. Its current Enterprise Value per Revenue stands at 2.317 whereas that against EBITDA is 15.195.
Stock Price History:
Over the past 52 weeks, SUPN has reached a high of $38.08, while it has fallen to a 52-week low of $21.99. The 50-Day Moving Average of the stock is -5.33%, while the 200-Day Moving Average is calculated to be 3.12%.
Shares Statistics:
For the past three months, SUPN has traded an average of 404.92K shares per day and 368040 over the past ten days. A total of 54.72M shares are outstanding, with a floating share count of 52.62M. Insiders hold about 4.28% of the company’s shares, while institutions hold 106.71% stake in the company. Shares short for SUPN as of 1713139200 were 4681164 with a Short Ratio of 11.56, compared to 1710460800 on 4924006. Therefore, it implies a Short% of Shares Outstanding of 4681164 and a Short% of Float of 12.879999999999999.
